Yann Mazabraud, EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 4,145 shares at $51.38 ($211K) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Open-market sale of $211k RYTM by EVP, Head of International. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.38 | 1,594 | $82K | 38.7% |
| 2 | $51.38 | 1,594 | $82K | 38.7% |
| 3 | $49.84 | 957 | $48K | 22.6% |
| Total | $51.02 avg | 4,145 | $211K | 100% |
| Filing → |
| RYTM | SELL | 2025-04-10 | $2.2M | — | Filing → |
| RYTM | SELL | 2025-03-18 | $7.7M | — | Filing → |
| RYTM | SELL | 2024-03-19 | $628K | — | Filing → |